Assessment of patient outcomes allows physicians and researchers to measure the success or failure of diagnostics and treatments that patients receive. One set of measurement tools…
Scientists at Barts and The London School of Medicine and Dentistry and Harvard Medical School, Boston have found a way of mimicking the body's natural mechanism of fighting inflammation.…
Researchers have solved the three-dimensional structure of a key biological receptor. The finding has the potential to speed drug discovery in many areas, from arthritis to respiratory…
A recent trial of rituximab in combination with a tumour necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile…
His design has earned a spot on the first-round shortlist of one of the world's most prestigious design competitions - the Australian Design Award/James Dyson Award…
Some biologic drugs may be safer than others according to a new systematic review by Cochrane researchers. Biologics are a broad class of drugs based on biological molecules. The drugs…
The American College of Rheumatology today announced the release of two new provisional definitions of rheumatoid arthritis remission, which are to be applied to future RA clinical…
An analysis of data from more than 90,000 Medicare managed care enrolees who received care for rheumatoid arthritis finds that more than one-third did not receive the recommended treatment…
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen…
Scientists have identified a protein that acts as a 'master switch' in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the…